EWTX
Edgewise Therapeutics IncNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$3.33B
P/E Ratio
—
EPS
$-1.63
Beta
0.25
52W High
$35.00
52W Low
$12.15
50-Day MA
$31.01
200-Day MA
$22.34
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
—
About Edgewise Therapeutics Inc
Edgewise Therapeutics, Inc., a biopharmaceutical company, develops small molecule therapies for musculoskeletal diseases. The company is headquartered in Boulder, Colorado.
Fundamentals
| Revenue (TTM) | 0 |
| Gross Profit (TTM) | 0 |
| EBITDA | $-189.32M |
| Operating Margin | 0.00% |
| Return on Equity | -34.20% |
| Return on Assets | -23.00% |
| Revenue/Share (TTM) | $0.00 |
| Book Value | $4.92 |
| Price-to-Book | 6.38 |
| Price-to-Sales (TTM) | — |
| EV/Revenue | - |
| EV/EBITDA | -2.60 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 0.00% |
| Shares Outstanding | $107.53M |
| Float | $67.62M |
| % Insiders | 0.46% |
| % Institutions | 115.79% |
Historical Volatility
HV 10-Day
39.19%
HV 20-Day
39.78%
HV 30-Day
41.44%
HV 60-Day
43.07%
HV Rank
6.3%
Volatility is currently contracting
Analyst Ratings
Consensus ($41.08 target)
3
Strong Buy7
Buy2
HoldData last updated: 4/29/2026